Fuji Pharma Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 7.97% vs 14.50% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -72.31% vs 115.47% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15,897.00",
          "val2": "14,723.00",
          "chgp": "7.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,790.00",
          "val2": "2,632.00",
          "chgp": "44.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "84.00",
          "val2": "93.00",
          "chgp": "-9.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2,501.00",
          "val2": "-250.00",
          "chgp": "-900.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "324.00",
          "val2": "1,170.00",
          "chgp": "-72.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "175.30%",
          "val2": "110.20%",
          "chgp": "6.51%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is 12.01% vs 12.84% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is -51.20% vs 78.95% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "51,677.00",
          "val2": "46,138.00",
          "chgp": "12.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,955.00",
          "val2": "7,561.00",
          "chgp": "18.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "330.00",
          "val2": "196.00",
          "chgp": "68.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-737.00",
          "val2": "1,345.00",
          "chgp": "-154.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,000.00",
          "val2": "6,147.00",
          "chgp": "-51.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "96.60%",
          "val2": "84.10%",
          "chgp": "1.25%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

15,897.00

14,723.00

7.97%

Operating Profit (PBDIT) excl Other Income

3,790.00

2,632.00

44.00%

Interest

84.00

93.00

-9.68%

Exceptional Items

-2,501.00

-250.00

-900.40%

Consolidate Net Profit

324.00

1,170.00

-72.31%

Operating Profit Margin (Excl OI)

175.30%

110.20%

6.51%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 7.97% vs 14.50% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -72.31% vs 115.47% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

51,677.00

46,138.00

12.01%

Operating Profit (PBDIT) excl Other Income

8,955.00

7,561.00

18.44%

Interest

330.00

196.00

68.37%

Exceptional Items

-737.00

1,345.00

-154.80%

Consolidate Net Profit

3,000.00

6,147.00

-51.20%

Operating Profit Margin (Excl OI)

96.60%

84.10%

1.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Sep 2025 is 12.01% vs 12.84% in Sep 2024

Consolidated Net Profit

YoY Growth in year ended Sep 2025 is -51.20% vs 78.95% in Sep 2024

All Annual Results